SKI Market

Indian Indices

Sensex

82,901.68 403.54
( 0.49%)

Global Indices

Nasdaq

49,410.74 -272.93
(-0.55%)

Dow Jones

6,881.90 -20.41
(-0.30%)

Hang Seng

56,838.27 -629.56
(-1.10%)

Nikkei 225

10,620.33 -65.85
(-0.62%)

Forex

USD-INR

90.70 0.01
(0.01%)

EUR-INR

107.23 -0.14
(-0.13%)

GBP-INR

122.83 -0.27
(-0.22%)

JPY-INR

0.59 0.00
(-0.51%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

16.5329749

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

221.25

49.38

EPS(TTM)

Face Value()

Div & Yield %

0.16

Back

glaxosmithkline pharma ltd

Tech Mahindra consolidated net profit rises 14.12% in the December 2025 quarter

Jan 16,2026

Net profit of Tech Mahindra rose 14.12% to Rs 1122.00 crore in the quarter ended December 2025 as against Rs 983.20 crore during the previous quarter ended December 2024. Sales rose 8.34% to Rs 14393.20 crore in the quarter ended December 2025 as against Rs 13285.60 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	14393.20	13285.60	8
OPM %	16.44	13.62	-
PBDT	2251.20	1756.20	28
PBT	1777.50	1297.40	37
NP	1122.00	983.20	14

82,901.68 403.54 ( 0.49%)

49,410.74 -272.93 (-0.55%)

6,881.90 -20.41 (-0.30%)

56,838.27 -629.56 (-1.10%)

10,620.33 -65.85 (-0.62%)

90.70 0.01 (0.01%)

107.23 -0.14 (-0.13%)

122.83 -0.27 (-0.22%)

0.59 0.00 (-0.51%)